GlassScriptPhysician profile
Bridgit M Fischer
NPI 1710118526
$329.91
in general payments reported to CMS, 2019-2025
11 companies · $109 in 2025
The $109 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $30.71 · 2022: $14.01 · 2023: $84.78 · 2024: $91.32 · 2025: $109.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $285.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $285.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $111.37 | 2024-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Ethicon US, LLC | $44.72 | 2021-2022 | |
| Janssen Biotech, INC. | $33.93 | 2023 | |
| Boston Scientific Corporation | $30.93 | 2023 | Rezum Generator |
| Abbvie INC. | $24.28 | 2024 | |
| Csl Behring | $19.92 | 2023 | Kcentra |
| Vertex Pharmaceuticals Incorporated | $18.04 | 2025 | |
| Pfizer INC. | $16.73 | 2024 | |
| Progenics Pharmaceuticals, INC. | $15.63 | 2024 | |
| Merit Medical Systems INC | $7.70 | 2024 | Savi Scout |
| Phathom Pharmaceuticals, INC. | $6.66 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bridgit Fischer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.